journal article·2024-12Open access

Engineering gene-activated bioprinted scaffolds for enhancing articular cartilage repair

Min Wang, Jiachen Wang, Xin Xu, Erliang Li, Peng Xu

Abstract

Untreated articular cartilage injuries often result in severe chronic pain and dyskinesia. Current repair strategies have limitations in effectively promoting articular cartilage repair, underscoring the need for innovative therapeutic approaches. A gene-activated matrix (GAM) is a promising and comprehensive therapeutic strategy that integrates tissue-engineered scaffold-guided gene therapy to promote long-term articular cartilage repair by enhancing gene retention, reducing gene loss, and regulating gene release. However, for effective articular cartilage repair, the GAM scaffold must mimic the complex gradient structure of natural articular cartilage. Three-dimensional (3D) bioprinting technology has emerged as a compelling solution, offering the ability to precisely create complex microstructures that mimic the natural articular cartilage. In this review, we summarize the recent research progress on GAM and 3D bioprinted scaffolds in articular cartilage tissue engineering (CTE), while also exploring future challenges and development directions. This review aims to provide new ideas and concepts for the development of gene-activated bioprinted scaffolds with specific properties tailored to meet the stringent requirements of articular cartilage repair.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Osteoarthritis Treatment and Mechanisms · 3D Printing in Biomedical Research · Bone Tissue Engineering Materials

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (100+)

Show source-provided references
1. Failure of cartilage regeneration: emerging hypotheses and related therapeutic strategies10.1038/s41584-023-00979-5 ↗
2. Injectable bioactive antioxidative one-component polycitrate hydrogel with anti-inflammatory effects for osteoarthritis alleviation and cartilage protection10.1002/adhm.202301953 ↗
3. Multiphasic scaffolds for the repair of osteochondral defects: outcomes of preclinical studies
4. Designing functional hyaluronic acid-based hydrogels for cartilage tissue engineering
5. Exquisite design of injectable hydrogels in cartilage repair10.7150/thno.46450 ↗
6. Regeneration of articular cartilage defects: therapeutic strategies and perspectives10.1177/20417314231164765 ↗
7. Smart biomaterials for articular cartilage repair and regeneration10.1002/adfm.202212561 ↗
8. Biomaterial-guided delivery of gene vectors for targeted articular cartilage repair10.1038/s41584-018-0125-2 ↗
9. Articular cartilage repair biomaterials: strategies and applications
10. Surgical and tissue engineering strategies for articular cartilage and meniscus repair10.1038/s41584-019-0255-1 ↗
11. The evolving landscape of gene therapy strategies for the treatment of osteoarthritis10.1016/j.joca.2023.12.009 ↗
12. Recent advances in polymeric biomaterials-based gene delivery for cartilage repair
13. Emerging strategies in reprogramming and enhancing the fate of mesenchymal stem cells for bone and cartilage tissue engineering10.1016/j.jconrel.2020.12.055 ↗
14. Cellular therapy and tissue engineering for cartilage repair10.1016/j.joca.2022.07.012 ↗
15. Hydrogel-based growth factor delivery platforms: strategies and recent advances10.1002/adma.202210707 ↗
16. Advanced hydrogels for the repair of cartilage defects and regeneration
17. 3D printed hydrogel for articular cartilage regeneration10.1016/j.compositesb.2022.109863 ↗
18. Application and development of 3D bioprinting in cartilage tissue engineering10.1039/D2BM00709F ↗
19. Advanced 3D-printing bioinks for articular cartilage repair10.18063/ijb.v8i3.511 ↗
20. Regenerative potential of perichondrium: a tissue engineering perspective10.1089/ten.teb.2021.0054 ↗
21. 3D bioprinting for the repair of articular cartilage and osteochondral tissue10.1016/j.bprint.2022.e00239 ↗
22. Articular cartilage and osteochondral tissue engineering techniques: recent advances and challenges
23. Comparative analysis of hyaline cartilage characteristics and chondrocyte potential for articular cartilage repair10.1007/s10439-023-03429-1 ↗
24. Heterogeneous characteristics of the CD90+ progenitors in the fibrocartilage of different joints10.1177/19476035231200359 ↗
25. Collagen: quantification, biomechanics and role of minor subtypes in cartilage10.1038/s41578-020-0213-1 ↗
26. Molecular transport in articular cartilage-what have we learned from the past 50 years?10.1038/s41584-018-0033-5 ↗
27. Harnessing nanomedicine for cartilage repair: design considerations and recent advances in biomaterials10.1021/acsnano.4c00780 ↗
28. Recent development in multizonal scaffolds for osteochondral regeneration
29. Skeletal interoception in osteoarthritis10.1038/s41413-024-00328-6 ↗
30. The immune microenvironment in cartilage injury and repair10.1016/j.actbio.2021.12.006 ↗
31. Enhancing stem cell therapy for cartilage repair in osteoarthritis-a hydrogel focused approach10.3390/gels7040263 ↗
32. Emerging potential of gene silencing approaches targeting anti-chondrogenic factors for cell-based cartilage repair10.1007/s00018-017-2531-z ↗
33. Mesenchymal stem-cell potential in cartilage repair: an update10.1111/jcmm.12378 ↗
34. Growth factor and its polymer scaffold-based delivery system for cartilage tissue engineering10.2147/IJN.S249829 ↗
35. FGF2: a key regulator augmenting tendon-to-bone healing and cartilage repair, Regener
36. Fibroblast growth factor signalling in osteoarthritis and cartilage repair10.1038/s41584-020-0469-2 ↗
37. Role of signaling pathways in age-related orthopedic diseases: focus on the fibroblast growth factor family
38. Species-specific biological effects of FGF-2 in articular cartilage: implication for distinct roles within the FGF receptor family10.1002/jcb.24129 ↗
39. Targeted delivery of FGF2 to subchondral bone enhanced the repair of articular cartilage defect10.1016/j.actbio.2018.01.039 ↗
40. Role of Sox9 in growth factor regulation of articular chondrocytes10.1002/jcb.25099 ↗
41. Exogenous bFGF promotes articular cartilage repair via up-regulation of multiple growth factors10.1016/j.joca.2013.06.006 ↗
42. Fibroblast growth factor control of cartilage homeostasis10.1002/jcb.24418 ↗
43. Fibroblast growth factor 18 exerts anti-osteoarthritic effects through PI3K-AKT signaling and mitochondrial fusion and fission10.1016/j.phrs.2018.09.026 ↗
44. Insulin-like growth factor-1 in articular cartilage repair for osteoarthritis treatment10.1186/s13075-021-02662-0 ↗
45. Chondrogenic differentiation of growth factor-stimulated precursor cells in cartilage repair tissue is associated with increased HIF-1α activity10.1016/j.joca.2008.04.006 ↗
46. Engineered artificial articular cartilage made of decellularized extracellular matrix by mechanical and IGF-1 stimulation10.1016/j.bioadv.2022.213019 ↗
47. IGF-I stimulation of proteoglycan synthesis by chondrocytes requires activation of the PI 3-kinase pathway but not ERK MAPK10.1042/BJ20041636 ↗
48. Cartilage-targeting mRNA-lipid nanoparticles rescue perifocal apoptotic chondrocytes for integrative cartilage repair10.1016/j.cej.2023.142841 ↗
49. The effects of different doses of IGF-1 on cartilage and subchondral bone during the repair of full-thickness articular cartilage defects in rabbits10.1016/j.joca.2016.09.010 ↗
50. Enhanced repair of articular cartilage defects in vivo by transplanted chondrocytes overexpressing insulin-like growth factor I (IGF-I)10.1038/sj.gt.3302515 ↗
51. Genetic modification of chondrocytes with insulin-like growth factor-1 enhances cartilage healing in an equine model10.1302/0301-620X.89B5.18343 ↗
52. TGF-β and osteoarthritis10.1016/j.joca.2007.02.005 ↗
53. An update on transforming growth factor-β (TGF-β): sources, types, functions and clinical applicability for cartilage/bone healing10.1002/jcp.22698 ↗
54. Articular cartilage tissue engineering: the role of signaling molecules10.1007/s00018-015-2115-8 ↗
55. Smad3 activates the Sox9-dependent transcription on chromatin10.1016/j.biocel.2008.10.032 ↗
56. Promising targets for therapy of osteoarthritis: a review on the Wnt and TGF-β signalling pathways
57. MEK/ERK and p38 MAPK regulate chondrogenesis of rat bone marrow mesenchymal stem cells through delicate interaction with TGF-β1/Smads pathway10.1111/j.1365-2184.2010.00682.x ↗
58. TGFβ-induced cartilage repair is maintained but fibrosis is blocked in the presence of Smad710.1186/ar1931 ↗
59. Engineering hyaline cartilage from mesenchymal stem cells with low hypertrophy potential via modulation of culture conditions and Wnt/β-catenin pathway10.1016/j.biomaterials.2018.11.036 ↗
60. BMP signaling pathways in cartilage and bone formation
61. Bone morphogenetic proteins for articular cartilage regeneration10.1016/j.joca.2018.03.007 ↗
62. Silencing Smad7 potentiates BMP2-induced chondrogenic differentiation and inhibits endochondral ossification in human synovial-derived mesenchymal stromal cells10.1186/s13287-021-02202-2 ↗
63. Articular cartilage repair using dedifferentiated articular chondrocytes and bone morphogenetic protein 4 in a rabbit model of articular cartilage defects10.1002/art.23380 ↗
64. Role and mechanism of BMP4 in regenerative medicine and tissue engineering10.1007/s10439-023-03173-6 ↗
65. BMP-6 is an autocrine stimulator of chondrocyte differentiation10.1359/jbmr.1999.14.4.475 ↗
66. Potent induction of chondrocytic differentiation of human adipose-derived adult stem cells by bone morphogenetic protein 610.1002/art.21779 ↗
67. Intra-articular delivery of synovium-resident mesenchymal stem cells BMP-7-loaded fibrous PLGA scaffolds for cartilage repair10.1016/j.jconrel.2019.04.002 ↗
68. BMP-7 inhibits cartilage degeneration through suppression of inflammation in rat zymosan-induced arthritis10.1007/s00441-011-1154-1 ↗
69. Periodic knee injections of BMP-7 delay cartilage degeneration induced by excessive running in rats10.1002/jor.20840 ↗
70. Hypertrophic differentiation during chondrogenic differentiation of progenitor cells is stimulated by Bmp-2 but suppressed by Bmp-710.1016/j.joca.2013.01.009 ↗
71. Regulation and function of SOX9 during cartilage development and regeneration10.1016/j.semcancer.2020.04.008 ↗
72. Chondrogenic differentiation of human mesenchymal stem cells via SOX9 delivery in cationic niosomes10.3390/pharmaceutics14112327 ↗
73. The role of microRNAs in the osteogenic and chondrogenic differentiation of mesenchymal stem cells and bone pathologies10.7150/thno.55664 ↗
74. Sox9 directs hypertrophic maturation and blocks osteoblast differentiation of growth plate chondrocytes10.1016/j.devcel.2011.12.024 ↗
75. Developmental regulation of Wnt/β-catenin signals is required for growth plate assembly, cartilage integrity, and endochondral ossification10.1074/jbc.M414275200 ↗
76. L-Sox5 and Sox6 drive expression of the aggrecan gene in cartilage by securing binding of Sox9 to a far-upstream enhancer10.1128/MCB.00695-08 ↗
77. Activation of the SOX-5, SOX-6, and SOX-9 trio of transcription factors using a gene-activated scaffold stimulates mesenchymal stromal cell chondrogenesis and inhibits endochondral ossification10.1002/adhm.201901827 ↗
78. Sox9 family members negatively regulate maturation and calcification of chondrocytes through up-regulation of parathyroid hormone-related protein10.1091/mbc.e09-03-0227 ↗
79. Mechanical stretch enhances COL2A1 expression on chromatin by inducing SOX9 nuclear translocalization in inner meniscus cells10.1002/jor.21528 ↗
80. Zinc-Finger Protein 145, Acting as an upstream regulator of SOX9, improves the differentiation potential of human mesenchymal stem cells for cartilage regeneration and repair10.1002/art.30430 ↗
81. Direct bone morphogenetic protein 2 and Indian hedgehog gene transfer for articular cartilage repair using bone marrow coagulates10.1016/j.joca.2014.11.008 ↗
82. Signaling pathways in cartilage repair10.3390/ijms15058667 ↗
83. Reprogrammed synovial fluid-derived mesenchymal stem/stromal cells acquire enhanced therapeutic potential for articular cartilage repair10.1177/19476035211040858 ↗
84. Sonic hedgehog improves redifferentiation of dedifferentiated chondrocytes for articular cartilage repair10.1371/journal.pone.0088550 ↗
85. Blocking vascular endothelial growth factor with soluble Flt-1 improves the chondrogenic potential of mouse skeletal muscle-derived stem cells10.1002/art.24153 ↗
86. Combined effects of connective tissue growth factor-modified bone marrow-derived mesenchymal stem cells and NaOH-treated PLGA scaffolds on the repair of articular cartilage defect in rabbits10.3727/096368913X669770 ↗
87. A pH-responsive metal-organic framework for the co-delivery of HIF-2α siRNA and curcumin for enhanced therapy of osteoarthritis10.1186/s12951-022-01758-2 ↗
88. Bioactive hydrogel scaffolds-advances in cartilage regeneration through controlled drug delivery10.2174/1381612821666150115150712 ↗
89. Recent advances in the hydrogel-based biomolecule delivery system for cartilage tissue engineering10.1155/2022/1899400 ↗
90. Exploring the evolution of tissue engineering strategies over the past decade: from cell-based strategies to gene-activated matrix10.1016/j.aej.2023.08.080 ↗
91. Harnessing nucleic acids nanotechnology for bone/cartilage regeneration
92. Genetically engineered stem cell-based strategies for articular cartilage regeneration10.1002/bab.1016 ↗
93. Non-viral vectors for gene-based therapy10.1038/nrg3763 ↗
94. Cartilage penetrating cationic peptide carriers for applications in drug delivery to avascular negatively charged tissues10.1016/j.actbio.2018.12.004 ↗
95. Short interfering RNA (siRNA)-based therapeutics for cartilage diseases10.1007/s40883-020-00149-z ↗
96. Controlled non‐viral gene delivery in cartilage and bone repair: current strategies and future directions
97. Gene delivery strategies for cartilage tissue engineering10.1016/j.addr.2006.03.005 ↗
98. Advances in biomaterial-mediated gene therapy for articular cartilage repair10.3390/bioengineering9100502 ↗
99. Lentivirus-mediated knockdown of aggrecanase-1 and -2 promotes chondrocyte-engineered cartilage formation in vitro10.1002/bit.22862 ↗
100. Protective effect of lentivirus-mediated siRNA targeting ADAMTS-5 on cartilage degradation in a rat model of osteoarthritis10.3892/ijmm.2013.1318 ↗